These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9491713)
1. [The selective inhibition of cyclooxygenase isoforms: a new approach to the search for effective and safe nonsteroidal anti-inflammatory drug agents]. Viktorov AP Lik Sprava; 1997; (5):106-11. PubMed ID: 9491713 [TBL] [Abstract][Full Text] [Related]
2. [Meloxicam]. Sternon J; Appelboom T Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452 [TBL] [Abstract][Full Text] [Related]
5. [Meloxicam--the balance of efficacy and safety]. Morović-Vergles J Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285 [TBL] [Abstract][Full Text] [Related]
6. Ischaemic colitis in a patient taking meloxicam. Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558 [TBL] [Abstract][Full Text] [Related]
7. Relative safety of meloxicam in NSAID-intolerant patients. Kosnik M; Music E; Matjaz F; Suskovic S Allergy; 1998 Dec; 53(12):1231-3. PubMed ID: 9930610 [No Abstract] [Full Text] [Related]
8. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis. Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326 [TBL] [Abstract][Full Text] [Related]
9. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs. Housholder GT; Chan JT J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801 [No Abstract] [Full Text] [Related]
10. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors]. Wigand R Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455 [No Abstract] [Full Text] [Related]
14. [The selective cox-2 inhibitor meloxicam and salicylate therapy]. Tóth K Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964 [TBL] [Abstract][Full Text] [Related]
15. [Clinical application of cyclooxygenase-2 inhibitors]. Dzielska-Olczak M; Olczak S Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270 [TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805 [TBL] [Abstract][Full Text] [Related]
17. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance. Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954 [TBL] [Abstract][Full Text] [Related]
18. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis]. Grishina EI Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474 [No Abstract] [Full Text] [Related]
19. [A new class of nonsteroidal anti-inflammatory agents: COXIBs]. Costantino S Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276 [No Abstract] [Full Text] [Related]
20. Meloxicam (Mobic) for osteoarthritis. Med Lett Drugs Ther; 2000 May; 42(1079):47-8. PubMed ID: 10859731 [No Abstract] [Full Text] [Related] [Next] [New Search]